Fibrinolysis

Fibrinolysis is a process that prevents blood clots from growing and becoming problematic. This is achieved through the action of several proteins that work together to dissolve the clot.

Overview

Fibrinolysis is a process that involves the breakdown of fibrin, a protein that forms a mesh-like structure to help form a stable blood clot. This process is an important part of the body's ability to heal after an injury. When a blood vessel is damaged, the body quickly forms a clot to stop the bleeding. Once the injury begins to heal, the body needs to remove the clot. This is where fibrinolysis comes into play.

Process

The process of fibrinolysis involves several steps. First, the enzyme plasminogen is converted into plasmin. This conversion is facilitated by the enzyme tissue plasminogen activator (tPA), which is released from the endothelial cells lining the blood vessels. Once formed, plasmin acts to break down the fibrin mesh, effectively dissolving the clot.

Role in Health and Disease

Fibrinolysis plays a crucial role in maintaining the health of the circulatory system. If the process is not functioning properly, it can lead to a number of health problems. For example, if fibrinolysis is too active, it can lead to excessive bleeding. On the other hand, if it is not active enough, it can lead to the formation of clots that can block blood vessels, leading to conditions such as stroke or deep vein thrombosis (DVT).

Treatment and Medication

Medications that promote fibrinolysis, known as fibrinolytic drugs, are often used in the treatment of conditions such as stroke and heart attack. These drugs work by increasing the activity of plasmin, helping to dissolve clots and restore normal blood flow.

See Also

• Coagulation
• Hemostasis
• Thrombosis

Fibrinolysis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia